The latest UK biotech financing insights are now live! Our findings show that 2025 was a year of strategic resilience as the UK stood its ground in a tough global market. ➡️ biotechfinance.org
Our message to the government and #Investors is clear: it’s time to deliver and deploy.
#InvestinBiotech
📅 [Event] – Join Guilhaume Debroas, Head of Investor Relations at MaaT Pharma, at the 8th edition of the #investor Forum Lyon Pole Bourse.
📍 Palais de la Bourse – Place de la Bourse, Lyon, France
🗓 September 23, 2025
#LyonPoleBourse #LyonForum2024 #InvestInBiotech #HealthcareInvestors
🌟 EyeBio’s achievements underscore the remarkable potential of 🧬#UKbiotech to deliver life-changing therapies ➡️ biotechfinance.org
Read the UK biotech financing report to explore how strategic investments are the key to solidifying the UK’s place as a global leader in #biotech
#InvestinBiotech
🔎 We’re excited to feature Autolus Therapeutics in the 🧬 UK #biotech financing report, highlighting their incredible achievements in advancing CAR T cell therapies for #Oncology and #AutoimmuneDiseases ➡️ t.co/gVjR6sdoTT
Read the full case study in the #UK biotech financing report📖
#InvestinBiotech
🚀 Have You Read the UK biotech financing report yet? ➡️ biotechfinance.org
Our latest #UKbiotech financing report is packed with inspiring case studies of companies securing funding to drive 🚀 innovation, fuel R&D, and strengthen the UK’s position as a #GlobalBiotech leader 👏
#InvestinBiotech
🚀 Dive into breakthroughs and bold investments driving the UK #biotech sector’s £3.5 billion success in the annual UK biotech financing 2024 report ➡️ biotechfinance.org
📣 The BIA highlights the sector's resilience, #Innovation, and ability to remain globally competitive.
#InvestinBiotech
Coming soon...👀
Be the first to explore the latest insights on UK #biotech financing. Our report launches this 📆 Monday – uncover key trends, top funding highlights, and what’s next for the sector 📈
#InvestinBiotech
